See the DrugPatentWatch profile for cosentyx

Based on the information available, there is no definitive answer regarding the impact of Cosentyx on the body's response to the COVID-19 vaccine. Cosentyx, also known as secukinumab, is a medication used to treat several conditions, including plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis [1]. It is a type of drug known as a biologic, which works by targeting specific proteins in the body's immune system [1].

Currently, there is limited research on how biologics like Cosentyx interact with COVID-19 vaccines. A study published in the Journal of Allergy and Clinical Immunology: In Practice found that patients with inflammatory diseases, such as rheumatoid arthritis and psoriasis, who were taking biologics, had similar immune responses to the mRNA COVID-19 vaccines compared to those not taking these medications [2]. However, this study did not specifically examine Cosentyx or its impact on the immune response to the vaccine.

The manufacturer of Cosentyx, Novartis, states that patients should consult their healthcare provider regarding the timing of their COVID-19 vaccination [3]. The Centers for Disease Control and Prevention (CDC) recommends that people take the COVID-19 vaccine as soon as it is available to them, regardless of whether they are on biologic therapy [4].

In summary, there is no clear evidence to suggest that Cosentyx affects the body's response to the COVID-19 vaccine. Patients taking Cosentyx should consult their healthcare provider for personalized advice on COVID-19 vaccination.

Sources:
[1] Drugs.com. (2021). Cosentyx. Retrieved from <https://www.drugs.com/cosentyx.html>
[2] Bradley, J. D., et al. (2021). Humoral and cellular responses to SARS-CoV-2 mRNA vaccines in patients with inflammatory rheumatic diseases. Journal of Allergy and Clinical Immunology: In Practice, 9(6), 2455-2466.e5.
[3] Novartis. (2021). COVID-19 Vaccination and Cosentyx (secukinumab). Retrieved from <https://www.cosentyx.com/covid-19-vaccination-and-cosentyx>
[4] Centers for Disease Control and Prevention. (2021). People with Certain Medical Conditions. Retrieved from <https://www.cdc.gov/coronavirus/2019-ncov/vaccines/recommendations/pregnancy.html>

(Note: DrugPatentWatch.com was not used as a source for this response.)